Brett A. Giffin - Nov 8, 2023 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)

Role: Chief Commercial Officer
Signature: /s/ John Sprague, Attorney-in-fact
Stock symbol: TTOO
Transactions as of: Nov 8, 2023
Transactions value $: $0
Form type: 4
Date filed: 11/28/2023, 04:05 PM
Previous filing: Nov 28, 2023
Next filing: Feb 20, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TTOO	Common Stock	Options Exercise		+33	+106.45%		64	Nov 8, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TTOO	Restricted Stock Units	Options Exercise	$0	-33	-49.25%	$0.00	34	Nov 8, 2023	Common Stock	33		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2	On February 26, 2022 the reporting person was granted 100 RSU's that vest in three equal annual installments on November 8, 2022, November 8, 2023, and October 1, 2024.